Literature DB >> 30333132

Applying the Monod-Wyman-Changeux Allosteric Activation Model to Pseudo-Steady-State Responses from GABAA Receptors.

Joe Henry Steinbach1, Gustav Akk1.   

Abstract

The Monod-Wyman-Changeux (MWC) cyclic model was described as a kinetic scheme to explain enzyme function and modulation more than 50 years ago and was proposed as a model for understanding the activation of transmitter-gated channels soon afterward. More recently, the MWC model has been used to describe the activation of the GABAA receptor by the transmitter, GABA, and drugs that bind to separate sites on the receptor. It is most interesting that the MWC formalism can also describe the interactions among drugs that activate the receptor. In this review, we describe properties of the MWC model that have been explored experimentally using the GABAA receptor, summarize analytical expressions for activation and interaction for drugs, and briefly review experimental results.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30333132      PMCID: PMC6277929          DOI: 10.1124/mol.118.113787

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  38 in total

1.  Benzodiazepines modulate GABAA receptors by regulating the preactivation step after GABA binding.

Authors:  Marc C Gielen; Michael J Lumb; Trevor G Smart
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

2.  Relaxation and fluctuations of membrane currents that flow through drug-operated channels.

Authors:  D Colquhoun; A G Hawkes
Journal:  Proc R Soc Lond B Biol Sci       Date:  1977-11-14

Review 3.  Understanding synergy.

Authors:  Nori Geary
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-04       Impact factor: 4.310

4.  Classic benzodiazepines modulate the open-close equilibrium in alpha1beta2gamma2L gamma-aminobutyric acid type A receptors.

Authors:  Dirk Rüsch; Stuart A Forman
Journal:  Anesthesiology       Date:  2005-04       Impact factor: 7.892

5.  High Constitutive Activity Accounts for the Combination of Enhanced Direct Activation and Reduced Potentiation in Mutated GABAA Receptors.

Authors:  Allison L Germann; Daniel J Shin; Christina R Kuhrau; Alexander D Johnson; Alex S Evers; Gustav Akk
Journal:  Mol Pharmacol       Date:  2018-02-08       Impact factor: 4.436

6.  On the nature of allosteric transitions: implications of non-exclusive ligand binding.

Authors:  M M Rubin; J P Changeux
Journal:  J Mol Biol       Date:  1966-11-14       Impact factor: 5.469

7.  Multiple propofol-binding sites in a γ-aminobutyric acid type A receptor (GABAAR) identified using a photoreactive propofol analog.

Authors:  Selwyn S Jayakar; Xiaojuan Zhou; David C Chiara; Zuzana Dostalova; Pavel Y Savechenkov; Karol S Bruzik; William P Dailey; Keith W Miller; Roderic G Eckenhoff; Jonathan B Cohen
Journal:  J Biol Chem       Date:  2014-08-01       Impact factor: 5.157

8.  Single-channel behavior of heteromeric alpha1beta glycine receptors: an attempt to detect a conformational change before the channel opens.

Authors:  Valeria Burzomato; Marco Beato; Paul J Groot-Kormelink; David Colquhoun; Lucia G Sivilotti
Journal:  J Neurosci       Date:  2004-12-01       Impact factor: 6.167

9.  A nonequilibrium binary elements-based kinetic model for benzodiazepine regulation of GABAA receptors.

Authors:  Marcel P Goldschen-Ohm; Alexander Haroldson; Mathew V Jones; Robert A Pearce
Journal:  J Gen Physiol       Date:  2014-07       Impact factor: 4.086

Review 10.  Analysis of drug combinations: current methodological landscape.

Authors:  Julie Foucquier; Mickael Guedj
Journal:  Pharmacol Res Perspect       Date:  2015-05-20
View more
  16 in total

1.  Reduced Activation of the Synaptic-Type GABAA Receptor Following Prolonged Exposure to Low Concentrations of Agonists: Relationship between Tonic Activity and Desensitization.

Authors:  Spencer R Pierce; Allison L Germann; Alex S Evers; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2020-09-25       Impact factor: 4.436

2.  Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant α1β3γ2L GABAA Receptors Indicates Selectivity and Crosstalk among Intersubunit Transmembrane Anesthetic Sites.

Authors:  Andrea Szabo; Anahita Nourmahnad; Elizabeth Halpin; Stuart A Forman
Journal:  Mol Pharmacol       Date:  2019-01-29       Impact factor: 4.436

3.  Steady-State Activation and Modulation of the Concatemeric α1β2γ2L GABAA Receptor.

Authors:  Allison L Germann; Spencer R Pierce; Ariel B Burbridge; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2019-07-01       Impact factor: 4.436

4.  The Sulfated Steroids Pregnenolone Sulfate and Dehydroepiandrosterone Sulfate Inhibit the α1β3γ2L GABAA Receptor by Stabilizing a Novel Nonconducting State.

Authors:  Spencer R Pierce; Allison L Germann; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2021-12-01       Impact factor: 4.436

5.  (+)-Catharanthine potentiates the GABAA receptor by binding to a transmembrane site at the β(+)/α(-) interface near the TM2-TM3 loop.

Authors:  Hugo R Arias; Cecilia M Borghese; Allison L Germann; Spencer R Pierce; Alessandro Bonardi; Alessio Nocentini; Paola Gratteri; Thanvi M Thodati; Natalie J Lim; R Adron Harris; Gustav Akk
Journal:  Biochem Pharmacol       Date:  2022-03-15       Impact factor: 6.100

6.  A strategy for determining the equilibrium constants for heteromeric ion channels in a complex model.

Authors:  Klaus Benndorf; Thomas Eick; Christian Sattler; Ralf Schmauder; Eckhard Schulz
Journal:  J Gen Physiol       Date:  2022-04-29       Impact factor: 4.000

7.  Intrasubunit and Intersubunit Steroid Binding Sites Independently and Additively Mediate α1β2γ2L GABAA Receptor Potentiation by the Endogenous Neurosteroid Allopregnanolone.

Authors:  Allison L Germann; Spencer R Pierce; Hiroki Tateiwa; Yusuke Sugasawa; David E Reichert; Alex S Evers; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2021-05-06       Impact factor: 4.054

8.  Perspective on the Relationship between GABAA Receptor Activity and the Apparent Potency of an Inhibitor.

Authors:  Allison L Germann; Spencer R Pierce; Alex S Evers; Joe Henry Steinbach; Gustav Akk
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

Review 9.  Electrophysiology of ionotropic GABA receptors.

Authors:  Erwan Sallard; Diane Letourneur; Pascal Legendre
Journal:  Cell Mol Life Sci       Date:  2021-06-01       Impact factor: 9.261

10.  Steady-state activation and modulation of the synaptic-type α1β2γ2L GABAA receptor by combinations of physiological and clinical ligands.

Authors:  Allison L Germann; Spencer R Pierce; Thomas C Senneff; Ariel B Burbridge; Joe Henry Steinbach; Gustav Akk
Journal:  Physiol Rep       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.